BackCytek BioSciences Overview

Cytek BioSciences Current Cash

Track Cytek BioSciences's current cash ($66M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$65.67M
↓ 31.10% YoYΔ $-29.63M vs prior year quarter

Peer average

Loading

Cytek BioSciences Current Cash History

Loading

Cytek BioSciences vs. peers: Current Cash Comparison

Loading

Cytek BioSciences Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Cytek BioSciences (CTKB) FAQ

The latest current cash for CTKB is $66M as of March 2026. That compares with $95M in the prior-year period — down 31.1% year over year. Investors often review this figure alongside Cytek BioSciences's historical trend and sector peers before judging valuation or financial health.

Over the past year, CTKB's current cash moved from $95M to $66M — a 31.1% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Cytek BioSciences's operating scale or balance-sheet position.

A current cash figure of $66M for CTKB is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting CTKB's current cash ($66M), review year-over-year change from $95M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Cytek BioSciences's current cash against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.